Cronos Group, Inc. (CRON)
3.38
-0.01
(-0.30%)
USD |
NASDAQ |
Aug 28, 16:00
3.375
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Price to Book Value : 1.172 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.172 |
| August 27, 2026 | 1.176 |
| August 26, 2026 | 1.232 |
| August 25, 2026 | 1.218 |
| August 24, 2026 | 1.183 |
| August 21, 2026 | 1.148 |
| August 20, 2026 | 1.117 |
| August 19, 2026 | 1.141 |
| August 18, 2026 | 1.114 |
| August 17, 2026 | 1.093 |
| August 14, 2026 | 1.089 |
| August 13, 2026 | 1.096 |
| August 12, 2026 | 1.100 |
| August 11, 2026 | 1.068 |
| August 10, 2026 | 1.041 |
| August 07, 2026 | 1.075 |
| August 06, 2026 | 1.065 |
| August 05, 2026 | 0.9436 |
| August 04, 2026 | 0.9748 |
| August 03, 2026 | 0.9817 |
| July 31, 2026 | 0.9817 |
| July 30, 2026 | 1.002 |
| July 29, 2026 | 0.9921 |
| July 28, 2026 | 0.9887 |
| July 27, 2026 | 0.9921 |
| Date | Value |
|---|---|
| July 24, 2026 | 0.9748 |
| July 23, 2026 | 0.9505 |
| July 22, 2026 | 0.9644 |
| July 21, 2026 | 0.9713 |
| July 20, 2026 | 0.9713 |
| July 17, 2026 | 0.9679 |
| July 16, 2026 | 0.954 |
| July 15, 2026 | 0.9505 |
| July 14, 2026 | 0.954 |
| July 13, 2026 | 0.954 |
| July 10, 2026 | 0.954 |
| July 09, 2026 | 0.9644 |
| July 08, 2026 | 0.954 |
| July 07, 2026 | 0.954 |
| July 06, 2026 | 0.9575 |
| July 02, 2026 | 0.9921 |
| July 01, 2026 | 0.9921 |
| June 30, 2026 | 0.9644 |
| June 29, 2026 | 0.9988 |
| June 26, 2026 | 0.9847 |
| June 25, 2026 | 0.9567 |
| June 24, 2026 | 0.9497 |
| June 23, 2026 | 0.9427 |
| June 22, 2026 | 0.9287 |
| June 18, 2026 | 0.9497 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Lexaria Bioscience Corp. | 3.610 |
| Target Group, Inc. (Canada) | -- |
| Tilray Brands, Inc. | 0.3727 |
| InMed Pharmaceuticals, Inc. | 0.6636 |
| NervGen Pharma Corp. | 19.92 |
Price to Book Value Related Metrics
| PE Ratio | 18.35 |
| PS Ratio | 7.193 |
| PEG Ratio | 0.0639 |
| Price to Free Cash Flow | 25.96 |
| Price | 3.38 |
| Earnings Yield | 5.45% |
| Market Cap | 1.253B |
| PEGY Ratio | 0.0639 |
| Normalized PE Ratio | 17.07 |